PharmaEngine Dirección
Dirección controles de criterios 1/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Hong-Ren Wang
Chief Executive Officer (CEO)
n/a
Compensación total
| Porcentaje del salario del CEO | n/a |
| Permanencia del CEO | 3.8yrs |
| Participación del CEO | 0.02% |
| Permanencia media de la dirección | sin datos |
| Promedio de permanencia en la Junta Directiva | 5.4yrs |
Actualizaciones recientes de la dirección
Recent updates
Would PharmaEngine, Inc. (GTSM:4162) Be Valuable To Income Investors?
Mar 30
How Much Did PharmaEngine's(GTSM:4162) Shareholders Earn From Share Price Movements Over The Last Five Years?
Feb 18Is PharmaEngine, Inc.'s (GTSM:4162) Stock On A Downtrend As A Result Of Its Poor Financials?
Jan 14
We're Not Counting On PharmaEngine (GTSM:4162) To Sustain Its Statutory Profitability
Dec 10CEO
Hong-Ren Wang
3.8yrs
Permanencia
Mr. Hong-Ren Wang, Ph D., is President of PharmaEngine, Inc. since January 20, 2021 and serves as Chief Executive Officer. Mr. Wang holds Ph.D. degree in Materials Science and Engineering from Massachusett...
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Representative Director | no data | sin datos | sin datos | |
| Representative Director | 6.8yrs | NT$2.33m | sin datos | |
| Representative Director | 6.5yrs | NT$2.33m | sin datos | |
| Independent Director | 5.4yrs | NT$1.73m | 0.0021% NT$ 290.3k | |
| Director | 3.3yrs | NT$816.00k | sin datos | |
| Independent Director | 3.3yrs | NT$596.00k | sin datos | |
| Independent Director | no data | sin datos | sin datos | |
| Representative Director | no data | sin datos | sin datos | |
| Chairman | no data | sin datos | sin datos |
5.4yrs
Permanencia media
Junta con experiencia: La junta directiva de 4162 se considera experimentada (5.4 años de antigüedad promedio).